Townhall: Price Controls Will Kill Pharmaceutical R&D

While imposing price controls on prescription medications may be well-intentioned, it should be clear to legislators that a move in that direction will only create a new set of intractable problems for American patients. Rather than being unable to afford medications, patients could be denied access to future drugs as well as those already on the market altogether.

You can read this opinion piece in The Townhall.

FacebooktwitterredditlinkedinFacebooktwitterredditlinkedin